The toll is physical and financial, with the medical cost of obesity hitting nearly $173 billion in 2019 in the U.S
Premium biotech-inspired branding
Eligibility Requirements When BCBS plans do cover Wegovy, coverage is generally based on meeting the following criteria: Obesity (BMI of 30 or higher) Overweight (BMI of 27 or higher) with at least one weight-related medical condition, such as hypertension, high cholesterol, or type 2 diabetes Coverage may also be available for other FDA-approved indications, including cardiovascular risk reduction and MASH treatment
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
124,125,126 The design concept of these multi-agonists is to simultaneously regulate multiple key metabolic pathways to achieve more effective control over blood sugar, body weight, and overall metabolic health